Galanthamine is one of the FDA approved medications, used for the treatment of cognitive decline treatment of Alzheimer’s disease (AD) in mild to moderate stages, so alkaloids with similar carbon nucleus could be molecules with promising AChE inhibition activity and neuroprotection [9]. The gene discussed is ACHE; the disease is Alzheimer disease.